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In vertebrates, enhanced translation of mRNAs in oocytes and early embryos entering M-phase is thought to occur through
polyadenylation, involving binding, hyperphosphorylation and proteolytic degradation of Aurora-activated CPEB. In starfish, an unknown
component of the oocyte nucleus is required for cyclin B synthesis following the release of G2/prophase block by hormonal stimulation. We
have found that CPEB cannot be hyperphosphorylated following hormonal stimulation in starfish oocytes from which the nucleus has been
removed. Activation of Aurora kinase, known to interact with protein phosphatase 1 and its specific inhibitor Inh-2, is also prevented. The
microinjection of Inh-2 restores Aurora activation, CPEB hyperphosphorylation and cyclin B translation in enucleated oocytes. Nevertheless,
we provide evidence that CPEB is in fact hyperphosphorylated by cdc2, without apparent involvement of Aurora or MAP kinase, and that
cyclin B synthesis can be stimulated without previous degradation of phosphorylated CPEB. Thus, the regulation of cyclin B synthesis
necessary for progression through meiosis can be explained by an equilibrium between CPEB phosphorylation and dephosphorylation, and
both aspects of this control may rely on the sole activation of Cdc2 and subsequent nuclear breakdown.
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Since the M-phase promoting factor (MPF) was first
identified in starfish oocytes as the heterodimeric protein
kinase cyclin B-cdc2 (Labbe et al., 1989; see Doree and
Hunt, 2002, for a detailed historical account), and alternate
phases of cyclin B accumulation and degradation were
recognized to be key events for entry into and exit from
mitosis (Murray and Kirschner, 1989), a considerable body
of experimental results has revealed sophisticated control
mechanisms responsible for cyclin B proteolysis and exit
from mitosis (see Peters, 2002). In contrast, and surpri-0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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possible regulatory mechanisms that might control cyclin B
translation and accumulation before onset of M-phase in
somatic cells.
However, much recent progress has been made in the
understanding of the mechanisms controlling the synthesis
of cyclin B (and some other regulators of the cell cycle, such
as c-mos) at the G2/M-phase transition during oocyte
meiotic divisions and early embryogenesis. Silent in G2-
arrested full-grown oocytes, cyclin B synthesis is activated
upon reinitiation of meiosis (both in vertebrates and
invertebrates), and gradually becomes the predominant
one. This control is required for prevention of DNA
replication within meiosis (Picard et al., 1996) and new
cyclin B synthesis is also required for progression from
meiosis I into meiosis II (Hochegger et al., 2001). Control of
cyclin B translation is mediated by mRNA polyadenylation
through the binding of regulatory proteins to nucleotide85 (2005) 200 – 210
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polyadenylation elements (CPE) are the target of a CPE-
binding protein (CPEB) which allows the binding of another
protein, the cleavage and polyadenylation-specific factor
(CPSF), necessary for the extension of the poly(A) tail by a
poly(A)polymerase (Mendez et al., 2000a,b). CPEB may
simultaneously control the initiation of translation by
interaction at the 3V end cap through maskin (Stebbins-
Boaz et al., 1999; Cao and Richter, 2002). Experiments in
both frog and mouse oocytes have led to an attractively
simple scheme whereby CPEB is first phosphorylated by the
protein kinase Aurora A for the onset of translation, then
destroyed by proteolysis (Hodgman et al., 2001; Mendez et
al., 2002; Groisman et al., 2002). Whereas it is generally
agreed that Aurora and CPEB are key elements for
differential control of protein translation in meiosis and
early development, the precise physiological role and the
mechanism of Aurora activation are still controversial.
Multiple possible regulatory phosphorylations in Aurora
kinase have been reported: by GSK3, by MPF and by
autophosphorylation (Walter et al., 2000; Littlepage et al.,
2002; Ma et al., 2003; Sarkissian et al., 2004). Furthermore,
the relative roles of Aurora and cdc2-cyclin B in the
phosphorylation of CPEB, and the actual necessity for
CPEB proteolysis to allow cyclin B synthesis (Mendez et
al., 2002), (Thom et al., 2003; Barnard et al., 2004) are not
clear.
The starfish oocyte has long proven to be a valuable
comparative model to Xenopus oocyte, due to several
simplifications in regulatory processes (see Kishimoto,
2003, for a review). The MAP kinase pathway is not
involved in MPF activation, since the increase of cdc2-
cyclin B kinase activity occurs before that of MAPK, and
protein synthesis is not necessary for the G2/M transition.
Less redundancy is found in key regulatory proteins, for
instance, only one cyclin B is involved in meiotic divisions
in starfish oocyte, whereas Xenopus has four, with cyclins
B2 and B5 being replaced by cyclins B1 and B4 during
entry into meiosis II (Hochegger et al., 2001). Prophase-
blocked starfish oocytes are induced to resume meiosis by
exposure to 1 methyladenine (1-MA), the physiological
hormone, and if however fertilization does not occur, they
arrest in interphase of the first mitotic division after
completion of meiosis I and II. As in Xenopus, it has long
been recognized that the rate of protein synthesis increases
upon meiosis reinitiation (Guerrier and Doree, 1975), in
particular cyclin, which is regulated by polyadenylation of
preexisting mRNAs (Rosenthal et al., 1982; Standart et al.,
1987).
There is evidence for a nuclear factor required for the
control of cyclin B translation in starfish oocytes (Galas et
al., 1993). This prompted us to investigate the relationship
with the CPEB-dependent pathway. In the present work we
describe the cloning of the starfish homologs of Aurora and
CPEB and show that enucleation prevents CPEB hyper-
phosphorylation and Aurora activation, which can both bereversed by microinjection of an inhibitor specific for
protein phosphatase 1. However, CPEB can be fully
phosphorylated by cdc2-cyclin B alone and cyclin B
synthesis can be stimulated without previous degradation
of phosphorylated CPEB. This leads to a model in which
cyclin translation is regulated by the balance of phosphor-
ylation/dephosphorylation controlling CPEB activity. Trip-
ping this switch depends on cdc2 kinase activation and
release of a protein phosphatase 1 inhibitor by nuclear
envelope breakdown without apparent necessity for Aurora
activation.Materials and methods
Starfish oocytes
The starfishes Astropecten aranciacus and Marthasterias
glacialis were collected by diving during the breeding
season near the marine biological station of Banyuls sur mer
(Banyuls, France) and kept in running sea water (SW).
Prophase-blocked oocytes were prepared free of follicle
cells by washing in calcium-free SW, before returning to
normal SW, and meiosis reinitiation was induced by
addition of 1 AM 1-methyladenine, as previously described
(Picard and Doree, 1984). Microinjections were performed
according to Hiramoto (1974) and enucleations as previ-
ously described (Picard et al., 1988a).
cDNA cloning
For isolation of M. glacialis Aurora and CPEB cDNA
fragments, we designed degenerate PCR primers corre-
sponding to evolutionally conserved peptides: GKFGNVY
and KIADFGWF for Aurora, GVPWDITE and DKHKY-
PIG for CPEB. PCR were performed from starfish cDNA
synthesized with Superscript (Rnase H) reverse tran-
scriptase (Invitrogen) using a mixture of RNAs extracted
from ovaries, mature oocytes and larvae with the Rneasy
midi kit (Quiagen). Two PCR products showing high
sequence homology with Aurora and CPEB were used to
design new primers for the obtainment of the full-length
cDNAs by RACE-PCR (Smart RACE cDNA amplification
kit, Clontech).
Recombinant proteins
The entire coding region of M. glacialis Aurora and
CPEB were cloned into the pET21b vector to produce the
full-length recombinant proteins. These proteins were
obtained in an insoluble form as inclusion bodies and
purified under denaturing conditions by gel filtration in 6 M
GuCl for antibody production. Soluble M. glacialis Aurora
with a 6-His c-terminal tag was produced in Escherichia
coli, purified on Ni-loaded chelating sepharose (Amersham)
with imidazole gradient elution. Soluble M. glacialis CPEB
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vitro translation (TNT T7 coupled reticulocyte lysate
system, Promega), according to manufacturer instructions.
C-mos was produced and microinjected as previously
described (Sadler et al., 2004). Recombinant protein
phosphatase lambda and human protein phosphatase inhi-
bitor-2 were purchased from Calbiochem.
Antibodies
Full-length M. glacialis Aurora and CPEB purified
recombinant protein were injected in rabbits. The antibodies
were affinity purified on the corresponding proteins coupled
to Affigel-10 beads (Biorad). Rabbit polyclonal antibodies
against full-length M. glacialis cyclin B (Offner et al., 2003)
were used for immunoprecipitation of cdc2-cyclin B. Anti-
active-ERK antibodies were from Santa Cruz Biotechnology
(sc-7383).
Immunological procedures
For Western blots, 10 A. aranciacus oocytes in 5 Al SW
were added to 15 Al loading buffer (Laemmli, 1970),
separated by SDS–PAGE, blotted and visualized by ECL
plus (Amersham). For immunoprecipitation, M. glacialis
oocytes were homogenized and frozen in 20 volume of IP
buffer (50 mM Tris–HCl, 150 mM NaCl, 25 mM NaF, 10
mM phenylphosphate, 5 mM Na pyrophosphate, 0.5 mM Na
orthovanadate, 0.1% Triton X-100, 0.1 mg/ml Soybean
Trypsin Inhibitor, pH 7.4). After thawing, sonication and
clearing by centrifugation for 10 min at 10,000 g, antibody
was added to the supernatant (10 Ag/ml) for 2 h at 4- and
recovered on 10 Al of protein A sepharose beads (Moreau
et al., 1998). For A. aranciacus oocytes, aliquots of 30
oocytes were dissolved with IP buffer to a volume of 60 Al,
treated similarly and 50 Al of supernatant was added with 4
Ag antibody and recovered on 10 Al of protein A sepharose.
Protein kinase activities
Histone H1 kinase activity was measured by in vitro
phosphorylation with 32P-ATP, gel electrophoresis and
scintillation counting of the H1 band. Two A. aranciacus
oocytes were used per measurement (Vee et al., 2001). A
similar procedure was used for Aurora kinase activity, with
0.3 mg/ml MBP instead of 0.1 mg/ml histone H1, and anti-
Aurora immunoprecipitates from either batches of 30 A.
aranciacus oocytes or of 50 Al M. glacialis egg pellet.
Oocyte labeling with 35S-methionine
Batches of 10 oocytes of A. aranciacus were pulse labeled
for 10 min in the presence of 300 ACi/ml 35S-methionine
(Amersham), transferred in SW containing 100 mM methio-
nine, fixed and processed for SDS–PAGE and autoradiog-
raphy of 35S incorporated into proteins (Galas et al., 1993).In vitro activation of Aurora
Soluble 6-His-tagged recombinant Aurora, prepared as
described above, was activated by incubation with a 20
molar excess of Inh-2 for 10 min at 20-C, in buffer A (20
mM Tris, 25 mM KCl, 2 mM MnCl2, 1 mM MgCl2, 1 mM
DTT, 40 Ag/ml BSA, pH 7.5), as described by Satinover
et al. (2004), before MBP-kinase assay. Anti-Aurora
immunoprecipitates from M. glacialis extract (or 1 Ag/ml
6-His-Aurora in IP buffer as control) were treated with Inh-2
in similar conditions. For preparation of active thiophos-
phorylated Aurora, cyclin B-cdc2 kinase activity from 20 ml
of M-phase M. glacialis extract was pulled down with 0.4
ml of p13suc1 beads, which were incubated with an equal
volume containing 0.8 mg of purified recombinant Aurora,
20 mM adenosine 5V-[g-thio]triphosphate (Sigma), 50 mM
MgCl2 and 80 mM HEPES pH 7.0, for 1 h at 25-C. The
activated Aurora was desalted on a column equilibrated with
PBS and concentrated by ultrafiltration to 5 mg/ml for
microinjection in A. aranciacus oocytes.
In vitro phosphorylation of CPEB
Anti-cyclin B or anti-Aurora immunoprecipitates from
1 ml M-phase extracts of M. glacialis oocytes were
equilibrated with phosphorylation buffer and beads were
incubated with an equal volume containing 35S-labeled
CPEB, obtained by in vitro translation in rabbit reticulocyte
lysate, for 2 h at 25-C. This final mixture contained 10%
reticulocyte lysate, in phosphorylation buffer with an ATP
regeneration system (20 mM HEPES, 100 mM NaCl, 10
mM MgCl2, 2 mM ATP, 20 mM creatine phosphate, 0.1
mg/ml creatine kinase, pH 7.0). The reaction was stopped
by addition of concentrated Laemmli loading buffer. CPEB
phosphorylation was inferred from modification of electro-
phoretic migration, detected by autoradiography after
SDS–PAGE.
Accession numbers
Aurora (EMBL accession no. AJ889572); CPEB (EMBL
accession no. AJ889573).Results
Enucleated oocytes fail to activate Aurora, to phosphorylate
CPEB and to translate cyclin B upon hormonal stimulation
Enucleated starfish oocytes still respond to 1-MA treat-
ment by an increase in cyclin B-cdc2 kinase activity and
subsequent oscillations, as in control oocytes (Picard et al.,
1988b; see also Fig. 1D). However, MPF activity, assessed
by cytoplasmic transfer in nucleated prophase-blocked
recipient oocytes, is not detectable or much smaller than
in controls (Kishimoto et al., 1981; Picard and Doree, 1984).
Fig. 1. CPEB phosphorylation is suppressed in enucleated oocytes. (A) Western blot with anti-CPEB of normal A. aranciacus oocytes taken at indicated time
after 1-MA addition. The migration position of unphosphorylated (P) and hyperphosphorylated (+P) CPEB is indicated. (B) Similar experiment to detail the
variations occurring around GVBD (with a different batch of oocytes). (C) Similar experiment with enucleated or normal (control) oocytes. (D) H1 kinase
activity (cpm) of enucleated (en) or normal (ctrl) oocytes treated or not for 60 min with 1-MA.
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enucleated oocytes after the injection of a small amount of
MPF does not occur but is restored when germinal vesicle
material is reinjected (Kishimoto et al., 1981; Picard and
Doree, 1984).
There is also a selective failure of cyclin B synthesis to
increase. In normal oocytes, pulse labeling with 35S-
methionine shows that cyclin B is one of the major newly
synthesized proteins after hormonal stimulation and nuclear
envelope breakdown (Standart et al., 1987; Galas et al.,
1993). By contrast, although global protein synthesis in
enucleated oocytes increased following stimulation by 1-
MA, cyclin B synthesis was not detected even though levels
of cyclin B mRNAs are not modified (Galas et al., 1993).
It is well documented that cyclin B translation relies on
CPEB-dependent polyadenylation, and CPE elements are
actually found in the 3V untranslated end of cyclin B mRNA
of both of our starfish species M. glacialis (Offner et al.,
2003) and A. aranciacus (unpublished result). Moreover,
Aurora A has been proposed to control CPEB interactions
and/or sensitivity to proteolytic degradation in vertebrate
oocytes (Mendez et al., 2000a).
In order to investigate how the nucleus controls cyclin B
translation in starfish oocytes, we first cloned their CPEBand Aurora homologs. The complete ORF of CPEB encodes
a polypeptide of 756 amino acids with a calculated
molecular weight of 82 kDa. The C-terminal part, contain-
ing the RNA-recognition motifs and the terminal zinc finger,
is highly homologous to CPEB in other animal species
(more details are given in Supplementary Fig. S1). Most of
the N-terminal part shows little sequence conservation,
except for the A and B destruction boxes. Only one form of
Aurora was found in starfish and there was no hint during
the molecular cloning for the existence of two forms. The
ORF encodes a polypeptide of 416 amino acids with a
calculated molecular weight of 46.7 kDa. As in all known
Aurora kinases (Giet and Prigent, 1999), the C-terminal part
corresponds to the highly conserved catalytic domain, while
the N-terminus is highly divergent, with the noticeable
absence of a KEN destruction box (more details are given in
Supplementary Fig. S2). These clones were expressed in
bacteria and the recombinant proteins used to raise poly-
clonal antibodies which were affinity purified. For in vitro
experiments, soluble 6-His-tagged Aurora could be pro-
duced from bacteria but in vitro translation in rabbit
reticulocyte lysates was necessary to obtain soluble CPEB.
Anti-CPEB Western blot of whole oocytes shows that
CPEB is present in prophase-blocked oocytes and shows a
Fig. 2. Aurora activation is suppressed in enucleated oocytes. (A) MBP-
kinase activity of anti-Aurora immunoprecipitates from normal (controls) or
enucleated A. aranciacus oocytes taken at the indicated time after 1-MA
addition. The autoradiography shows the radioactivity incorporated in MBP
after in vitro phosphorylation with 32P-ATP and electrophoresis. (B)
Western blot with anti-Aurora of A. aranciacus oocytes, normal or
enucleated, taken at the same time after 1-Ma addition as in panel A.
Fig. 3. Inhibition of phosphatases by okadaic acid allows CPEB phosphory-
lation and cyclin B synthesis in enucleated oocyte. Normal (controls) or
enucleated A. aranciacus oocytes were injected (+) or not () with 1 AM
okadaic acid (OA) and treated with 1-Ma for the indicated time (min). The
upper panel shows an anti-CPEB Western blot (CPEB) and the lower the
autoradiography of 35S-pulse labeling, for 10 min, in a similar experiment
(35S). The migration position of cyclin B is indicated by an arrow.
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addition (Figs. 1A and B), as previously described in other
species. It is well documented that this mobility shift is the
consequence of phosphorylation of CPEB on multiple sites
(Paris et al., 1991; Hake and Richter, 1994; Walker et al.,
1999; Thom et al., 2003). Despite some variation between
different batches of oocytes, this phosphorylation is first
apparent at the time of GVBD (35–40 min after 1-MA) and
reaches its highest level in the following 10 min. The level
of CPEB then declines and it cannot be detected by the time
of first polar body emission (about 80–90 min after 1-MA).
It never reappears during the completion of meiosis and the
final G2 arrest. This process is in accordance with results
obtained with Xenopus and Spisula oocytes (Thom et al.,
2003). There is also a good temporal correlation between the
beginning of CPEB mobility shift and cyclin B synthesis.
In enucleated oocytes, CPEBwas detectable but showed no
modification of electrophoretic mobility following hormone
addition (Fig. 1C), despite normal activation of H1-kinase
activity (Fig. 1D). At the time when control oocytes emit their
first polar body, CPEB was still abundant and remained in its
lowmobility form. The overall increase in the rate of synthesis
of most proteins (but not of cyclin B) observed in enucleated
oocytes upon 1-MA stimulation (Galas et al., 1993) apparently
does not depend on CPEB phosphorylation.
The polyclonal antibody that was raised against the whole
recombinant Aurora protein should not be subfamily specific,
since the catalytic core of all Auroras is highly similar. On
Western blots of whole oocyte homogenates, this antibody
labeled only one band, which is in favor of the existence of
only one form, since published A and B sequences for a given
species always yield slightly different theoretical molecular
weights. Analysis of Aurora by Western blot shows that this
protein is already present in prophase-blocked oocytes
(normal control oocytes as well as enucleated), and that
neither its abundance nor its electrophoretic mobility change
following hormonal stimulation (Fig. 2B). However, analysis
of the kinase activity of anti-Aurora immunoprecipitates
(using myelin basic protein as a substrate) gave evidence of
an increased activity following hormonal stimulation innucleated oocytes (Fig. 2A). The activity in prophase-
blocked oocytes was low but detectable, with some variation
between batches of oocytes (see Fig. 4C), it increased after 1-
MA addition, to reach its highest level in metaphase I, before
a significant decrease at the time of first polar body emission.
In contrast, in enucleated oocytes, there was no such clear
increase at the time corresponding to metaphase I in their
nucleated counterparts (Fig. 2A).
Inhibitor-2 of phosphatase 1 restores Aurora activity, CPEB
phosphorylation and cyclin B translation in enucleated
oocytes
The above results suggested that the nuclear factor may
control cyclin B synthesis by controlling CPEB phosphor-
ylation. Since both Aurora and CPEB are known to be
activated by phosphorylation, the unknown nuclear factor
might favor such phosphorylations either by enhancement
of kinase activity or by inhibition of protein phosphatases.
Numerous reports have stressed that serine/threonine protein
phosphatases exert a negative control on the onset of
meiosis reinitiation in a variety of oocyte species (Huchon et
al., 1981; Pondaven and Meijer, 1986; Goris et al., 1989;
Picard et al., 1989; Rime and Ozon, 1990). Moreover,
microinjection of PP1/PP2 phosphatase inhibitors, or of
germinal vesicle material, had similar effects on restoration
of MPF amplification in enucleated oocytes (Picard et al.,
1991), suggesting that nuclear material might stimulate
MPF amplification by inhibiting protein phosphatases. If
protein phosphatases are indeed the target of the nuclear
factor controlling cyclin B synthesis, microinjection of
okadaic acid should restore it, as well as CPEB phosphor-
ylation, in enucleated oocytes. We indeed found this to be
the case (Fig. 3). Protein phosphatase 1 has been found in
starfish oocytes (Pondaven and Cohen, 1987), and was a
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because it is a key regulator of early embryonic cell cycles
(Walker et al., 1992). Furthermore, the first member of the
Aurora family (Ipl1) was discovered in yeast as antagonist
of an associated phosphatase Glc7, homologous to protein
phosphatase 1 (PP1) (Francisco et al., 1994).
Inhibitor-2 (Inh-2) is a physiological inhibitor of PP1,
which has attracted attention by its frequent in vivo
association in regulatory multi protein complexes, as the
recently discovered trimers where Inh-2 and PP1 are
associatedwith protein kinases includingAurora A (Satinover
et al., 2004). Inhibitor-2 is also conserved in yeast, in which
it is required for Ipl1 function (Tung et al., 1995). Thus, Inh-
2 was chosen, since it shows high sequence conservation,
has a high affinity for PP1 and the human recombinant
protein is commercially available. It was injected in
enucleated oocytes at a final intracellular concentration of
15 AM, then batches of oocytes were processed for 35S-
pulse labeling and autoradiography. As shown in Fig. 4A,
cyclin B synthesis was dramatically stimulated following
hormonal stimulation in enucleated Inh-2-injected oocytes.
CPEB phosphorylation was also restored, to a level
comparable with that observed in normal oocytes, by Inh-
2 microinjection (Fig. 4B), as well as the MBP-kinase
activity of anti-Aurora immunoprecipitates (Fig. 4C).
Neither Aurora nor MAPK activities seem to be required for
CPEB phosphorylation
The above data were consistent with the view that Aurora
could phosphorylate CPEB, converting it into an active formFig. 4. Microinjection of Inh-2 in enucleated oocytes restores cyclin B translation
were enucleated (E) or enucleated and injected with 15 AM Inh-2 (E + I-2) or untr
10 min. Batches of 10 oocytes were submitted to SDS–PAGE and autoradiograph
blot with anti-CPEB of normal (controls) or enucleated A. aranciacus oocytes injec
time (minutes). (C) MBP-kinase activity of anti-Aurora immunoprecipitates from n
aranciacus oocytes taken at the indicated time after 1-MA addition. The auto
phosphorylation with 32P-ATP and electrophoresis.supporting polyadenylation and efficient translation of
cyclin B mRNAs. To investigate if Aurora activity is the
target of Inh-2 effect in enucleated oocytes, we first checked
if Inh-2 can directly activate Aurora. Bacterially produced
starfish Aurora has a low MBP-kinase activity, which is
indeed increased about five times by preincubation with
8 AM Inh-2 (Fig. 5A ‘‘direct’’), in accordance with published
results (Satinover et al., 2004). However, Aurora immuno-
precipitated from extracts of prophase-blocked starfish
oocytes could not be activated by in vitro addition of Inh-
2 (Fig. 5B, ‘‘G2’’) and Inh-2 had no effect on immunopre-
cipitates from M-phase extracts (Fig. 5B, ‘‘M’’). This lack of
effect could not result from the immunoprecipitation
procedure, since bacterially produced Aurora, treated in
the same way, was still activable by Inh-2 (Fig. 5A ‘‘IP’’).
The increase in activity was however only half that of the
direct treatment, since antibody binding probably reduced
accessibility to Inh-2.
We found that recombinant Aurora could also be
activated through in vitro phosphorylation by cdc2-cyclin
B immunoprecipitated from M-phase starfish extracts
(results not shown). We therefore investigated whether
microinjection of activated Aurora could, like Inh-2, trigger
CPEB phosphorylation in enucleated oocytes. To make sure
that Aurora activation could not be reversed by dephos-
phorylation, it was phosphorylated in vitro with adenosine
gamma-thiotriphosphate, instead of ATP. As shown in Fig.
5C, such thiophosphorylated Aurora had a high MBP-kinase
activity. However, injection of this active Aurora in
enucleated oocytes was not able to induce a change in
CPEB electrophoretic mobility (Fig. 5D)., CPEB phosphorylation and Aurora activation. (A) A. aranciacus oocytes
eated (ctrl). Then 1-MAwas added for 70 min before 35S-pulse labeling, for
y. The migration position of cyclin B is indicated by an arrow. (B) Western
ted (+) or not () with 15 AM Inh-2 and treated with 1-MA for the indicated
ormal or enucleated, microinjected with 15 AM Inh-2 (E + I-2) or not (E), A.
radiography shows the radioactivity incorporated in MBP after in vitro
Fig. 6. CPEB is hyperphosphorylated, in vitro, by cdc2 but not by Aurora.
(A) Autoradiography of 35S-labeled CPEB incubated for 2 h with an
immunoprecipitate, from M-phase M. glacialis extract, of non-immune
serum (C), anti-Aurora (Aur) and anti-cyclin B (CB). The migration position
of unmodified CPEB is indicated by an arrow and that of the slowest
migrating form by an arrowhead. (B) In a similar experiment, CPEB
incubated with anti-cyclin B immunoprecipitate was treated (+) or not ()
with lambda phosphatase. (C) Similar experiment in which CPEB was
incubated with anti-cyclin B immunoprecipitate for 0, 20, 60 or 120 min.
Fig. 7. MAP-kinase activation is not required for hyperphosphorylation of
CPEB. Western blot with anti-CPEB (CPEB) or anti-active MAPK
(MAPK) of normal (nucl) or enucleated (en) A. aranciacus oocytes
injected with recombinant mos protein (mos) or treated with emetine (emet)
and treated with 1-Ma for the indicated time (min).
Fig. 5. Inhibitor-2 activates bacterially produced but not endogenous
Aurora, and activated Aurora does not induce CPEB phosphorylation, when
microinjected in enucleated oocytes. (A) MBP-kinase activity of bacterially
produced starfish Aurora treated (+) or not () with Inh-2 (8 AM for 10 min
at 20-C), either directly (direct) or after immunoprecipitation with anti-
Aurora (IP). The autoradiography shows the radioactivity incorporated in
MBP after in vitro phosphorylation with 32P-ATPand electrophoresis. (B)
MBP-kinase activity of anti-Aurora immunoprecipitates from extracts ofM.
glacialis oocytes blocked in prophase (G2) or in M-phase (M) and treated
(+) or not () with Inh-2 (8 AM for 10 min at 20-C). (C) MBP-kinase
activity of bacterially produced starfish Aurora incubated (+) or not ()
with purified cdc2-cyclin B from M-phase M. glacialis extract, and
adenosine thiotriphosphate. The autoradiography shows the radioactivity
incorporated in MBP after in vitro phosphorylation with 32P-ATP and
electrophoresis. (D) Western blot with anti-CPEB of enucleated A.
auranciacus oocytes injected (en+ Aur) or not (en) with thiophosphorylated
Aurora before a 60-min treatment with 1-MA, or normal oocytes (ctrl)
treated for 50 min with 1-MA.
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labeled starfish CPEB produced in rabbit reticulocyte
lysates, also showed no effect of Aurora on CPEB electro-
phoretic mobility, whereas highly phosphorylated forms of
CPEB could be obtained by incubation with active starfish
cdc2-cyclin B immunoprecipitates (Fig. 6A). Disappearance
of slowly migrating CPEB upon treatment with lambda
phosphatase (Fig. 6B) and the kinetics upon incubation with
cdc2-cyclin B for increased durations (Fig. 6C) are addi-
tional evidences to attribute the reduction in electrophoretic
mobility to multiple phosphorylations. Thus, starfish CPEB
can be hyperphosphorylated by cdc2 without requirement
for Aurora or another kinase.
It was previously demonstrated that, following 1-MA
addition, a high cdc2 kinase activity develops in enucleated
oocytes, synchronous with that in control oocytes (Picard et
al., 1988b; see also Fig. 1D). Thus, enucleation would not
be expected to prevent CPEB mobility shift if it is due to
phosphorylation by cdc2-cyclin B. Since Inh-2 injection
restores CPEB phosphorylation in enucleated oocytes, this
suggested that CPEB phosphorylation by cdc2 kinase is
constantly reversed by a high protein phosphatase 1 activity
present in the cytoplasm of enucleated oocytes, and that
nuclear envelope breakdown allows CPEB phosphorylation
by inhibiting PP1.
In Xenopus oocytes, the Mos-MAP kinase cascade
appears to be required for hormone-induced cyclin B
polyadenylation, although is dispensable if cdc2 is acti-
vated independently of mos (de Moor and Richter, 1997),while in starfish enucleated oocytes do not activate MAPK
in response to 1-MA (Abrieu et al., 1997). It is thus
possible that the starfish nuclear factor controlling cyclin B
synthesis acts not only to suppress PP1 activity, but also to
stimulate the MAP kinase cascade. However, CPEB
hyperphosphorylation was still observed in hormone-
stimulated nucleated starfish oocytes treated with emetine,
which suppressed mos translation and accordingly MAPK
activation (Fig. 7, lane2). Even when MAPK activity was
restored by microinjecting recombinant mos protein, no
phosphorylation of CPEB was detected (Fig. 7, lane 1). We
conclude that failure of enucleated oocytes to phosphor-
L. Lapasset et al. / Developmental Biology 285 (2005) 200–210 207ylate CPEB in response to hormonal stimulation is not due
to the lack of MAPK activity, but rather due to failure to
inhibit PP1 phosphatase.
CPEB degradation is not required for cyclin B translation
It has been demonstrated that CPEB undergoes proteol-
ysis following its phosphorylation (Mendez et al., 2002).
Although challenged in Spisula oocytes (Thom et al.,
2003) and the latest report in Xenopus oocytes (Barnard et
al., 2004), this proteolysis was proposed to be required for
cyclin B translation in Xenopus oocytes. In starfish, CPEB
also undergoes proteolysis following its cyclin B-cdc2
kinase-dependent phosphorylation in intact oocytes. In fact
CPEB is scarcely detectable in whole homogenates
prepared from oocytes after completion of meiotic matura-
tion (pronucleus stage) (Figs. 1A and 8B), when trans-
lation of only cyclin B readily occurs (Fig. 8A). However,
we observed, by Western blot analysis, that enucleated
oocytes fail to degrade CPEB at any time, even when they
are induced to readily translate cyclin B through Inh-2
microinjection (Fig. 8B). We conclude that control of
cyclin B translation by CPEB is regulated by a phosphor-
ylation/dephosphorylation equilibrium but not by CPEB
degradation.Fig. 8. CPEB degradation is not required for cyclin B translation. (A) Only
cyclin B translation readily occurs after completion of meiotic maturation.
Autoradiography of 35S-pulse labeling, for 10 min, of A. aranciacus
oocytes taken at the indicated time after 1-MA addition. The migration
position of cyclin B is indicated by an arrow. The occurrences of germinal
vesicle breakdown (GVBD), polar bodies emission (pb1, pb2) and of the
pronucleus stage (PN) are indicated. (B) Western blot with anti-CPEB of
normal (controls) or enucleated oocytes injected with Inh-2 (E + I-2) and
treated with 1-Ma for the indicated time (min).Discussion
In the present work, we provide evidence that PP1 (or
another phosphatase sensitive to inhibitor-2) suppresses
cyclin B translation until breakdown of the nuclear
envelope, which delivers to the cytoplasm a potent trans-
lational activator, most likely a PP1 inhibitor. This nuclear
factor is not a general translational activator, since trans-
lation of most proteins increases to similar levels following
hormonal stimulation in control and enucleated oocytes
(Galas et al., 1993), possibly due to phosphorylation of
ribosomal proteins S6 and S1 (Peaucellier et al., 1988). It
appears to be specific for cyclin B and a limited number of
other proteins. We previously reported that microinjection of
the content of supernumerary nuclei in nucleated oocytes
increased in a dose-dependent fashion cyclin B translation,
without having such an effect on translation of other
proteins. We have now found that microinjection of
recombinant inhibitor-2 of PP1 restores cyclin B translation
specifically in enucleated oocytes to levels higher than
nucleated oocytes.
The specific pattern of cyclin B synthesis depends on
polyadenylation of its mRNA through the binding of CPEB
to cytoplasmic polyadenylation elements in the 3V untrans-
lated part (Mendez et al., 2000a,b). According to the current
model, CPEB plays an inhibitory role in the control of
polyadenylation, and inhibition is released upon its phos-
phorylation and/or proteolytic degradation. Since onset of
cyclin B translation is nicely correlated with CPEB
phosphorylation in both nucleated oocytes at the time of
nuclear envelope breakdown and hormone-stimulated
enucleated oocytes injected with Inh-2, and neither CPEB
phosphorylation nor cyclin B translation occurs in non-
injected hormone-stimulated enucleated oocytes, PP1 may
negatively control production of cyclin B by reversing
CPEB phosphorylation, itself required for translation of
cyclin B mRNAs. Our finding that degradation of CPEB in
fully matured arrested oocytes is correlated with a high
translational level of cyclin B only, not observed in
enucleated oocytes that never phosphorylate nor degrade
CPEB, provides additional support to this interpretation.
Experiments in Xenopus and mouse oocytes led to the
view that CPEB must first be phosphorylated by Aurora A
for the onset of cyclin B translation (Mendez et al., 2000a;
Hodgman et al., 2001; Mendez et al., 2002; Groisman et al.,
2002). This scheme was attractive for us, because as with
human Aurora, recombinant starfish Aurora could be
activated by direct interaction with Inh-2. Nevertheless, this
model does not appear to be valid for starfish oocytes. The
present results cannot exclude that CPEB is an in vivo
substrate for Aurora, since in Xenopus this phosphorylation
does not induce noticeable electrophoretic mobility shift.
However, in starfish as in Spisula, there is no apparent
homology for the LDS/TR motif which is the target of
Aurora phosphorylation. Consistently, microinjected
recombinant Aurora failed to phosphorylate starfish CPEB
L. Lapasset et al. / Developmental Biology 285 (2005) 200–210208after irreversible activation through thiophosphorylation,
catalyzed by cyclin B-cdc2 in vitro, but this result may also
be explained by the requirement for other phosphatase-
sensitive steps, downstream of Aurora action. Possibly, the
Inh-2-like nuclear inhibitor that activates cyclin B trans-
lation in starfish found an additional target in this control
mechanism when CPEB evolved to become a substrate of
Aurora in vertebrates.
In vertebrates, degradation of CPEB subsequent to its
phosphorylation by cdc2 was reported to be required for
cyclin B translation (Mendez et al., 2002), although this
view was challenged recently (Barnard et al., 2004). It is
clear from our results that there is no requirement for CPEB
degradation for cyclin B translation in starfish oocytes, even
though CPEB almost completely disappears from oocytes
before completion of meiotic maturation, when translation
of only cyclin B readily occurs. In another invertebrate,
Spisula, CPEB proteolysis should also not be required
since, once maximally phosphorylated, CPEB no longer
associated with mRNAs (Thom et al., 2003).
In Spisula, where CPEB also lacks the LDSR Aurora
phosphorylation motif, a preliminary phosphorylation by
MAP kinase seems to be necessary for further phosphor-
ylation by cdc2 (Katsu et al., 1999). Even though MAP
kinase is suppressed in enucleated oocytes of at least M.
glacialis and A. aranciacus (Abrieu et al., 1997), no
phosphorylation of CPEB was detected when MAPK
activity was restored by microinjecting recombinant mos.
Moreover, CPEB hyperphosphorylation was still observed
in hormone-stimulated oocytes treated with emetine, which
suppressed mos translation and accordingly MAPK activity.
Finally, in starfish oocytes lacking in mos protein and
accordingly MAPK activity, embryonic mitotic cycles that
consist of alternating S- and M-phases (which requires
cyclin B synthesis) proceed immediately after exit from
meiosis I (Tachibana et al., 2000). Taken together, these
results do not support a role for MAPK in phosphorylation
of starfish CPEB. On the contrary, cdc2 kinase appears to be
the effector for release of CPEB-dependent inhibition of
cyclin B translation. In starfish, its activity increases very
shortly after 1-MA addition, it is maximal before the
beginning of CPEB phosphorylation and, even alone, it is
able to hyperphosphorylate CPEB in vitro, at difference
with Spisula. In vertebrates, also, MAP kinase activation is
not required for CPEB phosphorylation and cyclin B
translation if cdc2 kinase is first activated (de Moor and
Richter, 1997).
Since CPEB phosphorylation is the closest event to
cyclin B translation, we can assume that it is the target of the
Inh-2-sensitive phosphatase evidenced here. This is in
agreement with the demonstration that all phosphorylation
sites on Xenopus CPEB can be dephosphorylated in vitro by
PP1, as well as an Inh-2-sensitive phosphatase of oocytes
extracts (Tay et al., 2003). The existence of PP1 and of an
endogenous Inh-2 has been demonstrated in homogenates of
starfish oocytes (Pondaven and Cohen, 1987), but thepresent work raises the problem of their intracellular
localization. Prophase-blocked oocytes are in a G2 physio-
logical state and reports from the literature indicate that not
only Inh-2, but also PP1 should be expected to be mostly in
the nucleus at that time (Kakinoki et al., 1997; Smith et al.,
1998). However, the effect of Inh-2 injection in enucleated
oocytes indicates the existence of PP1 activity in the
cytoplasm. This can be accounted for if low amounts of
PP1 are concentrated in special spots, through localized
multiproteic complexes. There are several reports of such
complexes, involving PP1 localized at the centrosome (Eto
et al., 2002), actin cytoskeleton (Terry-Lorenzo et al., 2002)
or associated with membranes (Wang and Brautigan, 2002).
The elaboration of new biochemical tools will be necessary
to obtain a direct demonstration, but the present results lead
to a scheme where compartmentalization is essential for the
sequence of events. CPEB, unphosphorylated in G2/
prophase-blocked oocytes, is subjected to the antagonistic
action of cdc2 kinase and of PP1 after hormone addition.
One can assume that before nuclear envelope breakdown,
localized PP1 activity is dominant and that an Inh-2-like
inhibitor is sequestered in the nucleus. At the G2 to M-phase
transition, changes in nucleocytoplasmic traffic and nuclear
envelope integrity allows the release of the inhibitor in the
cytoplasm. The resulting inhibition of PP1 allows full
phosphorylation of CPEB and the ensuing polyadenylation,
then translation of cyclin B mRNAs. This scheme may be an
oversimplification since more than one step, leading to
cyclin B synthesis, may be controlled by the Inh-2-sensitive
phosphatase. Aurora is still such a possible mediator, despite
the lack of evidence stated above, as the significance of its
activation remains to be elucidated.Acknowledgments
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